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Editorials

Redox biology in physiology and disease
The perception of reactive oxygen species (ROS) and free radicals as
damaging and toxic byproducts of cellular function has undergone a
rapid evolution in the last few decades, which has given rise to the era
of redox biology. As new research emerges demonstrating the vital
importance of these molecules to normal physiological processes, the
concept of ROS acting in a purely detrimental nature is now antiquated.
However, this new functional awareness does not mean these reactive
species are harmless. To the contrary, dysregulation of the tight control
of these volatile messengers may lead to irreversible cellular damage
and pathology, which defines true oxidative stress. Yet, the line between physiological redox signaling and oxidative stress remains
blurred, and a dearth of literature exists that attempts to firmly delineate these two biological phenomena. In this special issue entitled
“Redox Biology in Physiology and Disease,” we highlight the work from
11 different research groups investigating the role of redox biology in
normal and pathological states. In addition to their contributions to this
special issue, these investigators all participated in the inaugural research symposium entitled “Redox Biology in Physiology and Disease”
held at the 2018 Experimental Biology Meeting in San Diego, California
that was jointly sponsored by the Society for Redox Biology and
Medicine (SfRBM) and the American Physiological Society (APS), and is
planned to be held at future meetings on a biennial basis.
Given that redox biology is pervasive across virtually all cell types
and biological systems, the research in this special issue covers many
diverse topics such as inflammation, cardiovascular disease, renal
function, airway disease, cancer, muscle biology, and neuroscience. For
example, Dr. Adam Case and colleagues provided an original research
manuscript examining the effects of uncontrolled mitochondrial superoxide (O2•-) on normal T-lymphocyte physiology [1]. Using conditional and inducible manganese superoxide dismutase (MnSOD) knockout mice, they demonstrated that an increase in steady-state mitochondrial O2•- produced significant alterations in cellular metabolism,
which ultimately affected T-lymphocyte activation and function.
Moreover, they provide evidence that increased mitochondrial O2•- may
also be disrupting nuclear epigenetic control via an alteration in cellular metabolite pools. This tight link between redox biology, metabolism, and genetic control illustrates the vital interconnections of biological systems, and reemphasizes the importance of moving the field to
more systems based approaches when examining these pathways. In
another original research manuscript examining the immune system,
Dr. Gábor Csányi's laboratory outlines the role of the neurofibromatosis
type 1 (NF1) gene in macrophage function [2]. They show that the loss
of NF1 in macrophages led to increased NADPH oxidase 2 (NOX2) activity, which caused an increase in exosome uptake by micropinocytosis. This enhanced exosome absorption increased the pro-inflammatory phenotype of the macrophages, which may have significant
relevance to patients with NF1 mutations who have a high risk of

inflammatory conditions like cardiovascular disease.
Cardiovascular disease is the number one cause of death worldwide.
While clinical trials using nonspecific antioxidants have not been successful in the amelioration of this disease, the appreciation and understanding of redox signaling, as opposed to oxidative stress, in the
cardiovascular system has grown exponentially over the past decade,
which gives hope for the potential of new redox-based therapeutic
strategies for this immense public health concern. This special issue
presents four excellent contributions in the area of redox biology in
cardiovascular physiology and disease. First, Dr. Matthew Zimmerman
and colleagues provide a mechanistic investigation into the redox signaling involved in neurogenic hypertension [3]. In this manuscript,
they show that the pro-hypertensive peptide angiotensin II is able to
initiate an intracellular signaling cascade in neurons via specific oxidation of the enzyme calcium/calmodulin-dependent protein kinase II
alpha (CamKIIα). By using site-directed mutagenesis of CamKIIα, they
elegantly demonstrate the necessity of redox signaling through this
enzyme to potentiate angiotensin II-mediated hypertension. Another
contribution examining redox signaling in cardiovascular disease is
from Dr. Rajasekaran Soorappan, who provided an investigation into
the role of nuclear factor erythroid 2-related factor 2 (Nrf2) signaling
during cardiac remodeling [4]. Using a mouse model of Nrf2 overexpression combined with isoproterenol-induced cardiac stress, the
authors demonstrate significant protection from cardiac remodeling as
a result of enhanced antioxidant signaling through Nrf2. The authors
identify a possible new mechanism of Nrf2 contributing to this reduction in pro-oxidant stress, which suggests the potential for new therapeutic approaches for cardiac remodeling in regards to Nrf2 activation. In another manuscript examining cardiac remodeling, Dr. ShinnZong Lin and colleagues utilize adipose-derived stem cells in attempts
to attenuate pathology to the heart during hypertension [5]. They demonstrate that stem cells pretreated with the antioxidant-promoting
compound n-butylidenephthalide demonstrated better engraftment and
decreased inflammation in the hearts of spontaneously hypertensive
rats, which overall attenuated the hypertension-induced cardiac pathology. Last, moving away from the heart, Dr. Paul O'Connor provides
an excellent examination into the mitochondrial redox environment in
the kidney [6]. By exhaustively examining the role of voltage-gated
hydrogen channel 1 (Hv1) using novel Hv1 knock-out rats, the authors
report the new observation of Hv1 translocation to the mitochondria
and modulation of the redox environment through complex I. Considering the important role of the kidney in numerous cardiovascular
diseases, this study provides a potential new redox-modulating therapeutic target for future investigations. Together, these manuscripts
offer a diverse view into the various research areas of redox biology in
the cardiovascular system.
In other areas of physiology and disease, this special issue provides
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works relevant to pulmonary diseases, cancer, muscle physiology, and
neurobiology. First, Drs. Joseph Sisson and Michael Price provide an
excellent review article summarizing the redox regulation of cilia as it
pertains to normal and pathological lung function [7]. They discuss the
importance of redox balance in the maintenance of ciliary function, and
examine how smoking, alcohol, and pulmonary diseases upset this
balance leading to dysfunction. Next, two outstanding review articles
are provided discussing redox modulation as a potential therapeutic
target in cancer. Dr. Arnold Stern and colleagues provide the first of
these reviews where he offers evidence as to the importance of nitric
oxide and hydrogen sulfide signaling in various malignancies [8]. They
propose that the use of nitric oxide and hydrogen sulfide donors that
produce supraphysiological concentrations of these molecules may be
effective strategies in the war on cancer. In the other review by Dr.
Shazib Pervaiz, the role of protein phosphatase 2A (PP2A) is discussed
with relevance to cancer [9]. The authors provide a convincing argument that redox regulation of PP2A is vital in various malignant states,
thus suggesting implications for PP2A targeting in therapeutic management of cancer. Switching to muscle physiology, Dr. Jonathan Fisher
and colleagues provide an original research manuscript elucidating a
novel glucose-sensing mechanism of muscle cells [10]. The authors
show that elevated extracellular glucose levels altered both the intracellular and extracellular redox environments leading to altered
glucose uptake and metabolic states, which appeared to be dependent
upon NOX activation. This work may have broad reaching implications
ranging from normal muscle physiology to diabetes. Last, Dr. Jay Dean
offers a wonderful review examining the neurological effects of hyperbaric oxygen [11]. Hyperbaric oxygen therapy is a double-edged
sword as while it provides many beneficial effects for specific pathological conditions, it also may create unique pathology due to overt
oxygen toxicity. This review provides an overview of hyperbaric oxygen
and central nervous system function, and provides significant clinical
relevance in regards to military personnel regularly performing deep
sea missions.
In summary, this special issue devoted to redox biology in both
physiological and pathophysiological conditions covers an array of topics. Yet, these 11 manuscripts only scratch the surface in regards to the
universal nature of redox chemistry in the biology of life. A significant
amount of work is still needed to delineate the normal and pathological
roles of redox species, but this will not be successful in a vacuum. In
order to make real progress in developing novel redox-based therapeutics for the improved treatment of human disease, investigations
must focus more on modulating redox signaling and less on decreasing
levels of oxidative stress biomarkers. It is the purpose of this special
issue as well as the biennial Experimental Biology symposium to
showcase the importance of cross-discipline research to advance the
knowledge of redox biology. By bridging the divide between various

*

fields of research, we hope to provide novel information regarding the
crucial difference between redox biology and oxidative stress in the
pathogenesis of human disease. In doing so, we speculate future investigations will continue to unveil how redox biology shapes life and
how it may be targeted to minimize pathology.
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